Robokinetics

Robokinetics operates within the neurorehabilitation and medical device sectors, specializing in robotic rehabilitation technology for personalized upper-limb therapy. The company differentiates itself through patented 6-DOF isokinetic force-control technology, which provides real-time adaptive resistance and support tailored to individual patient performance. While specific commercial competitor data is sparse in current public records, Robokinetics positions its offerings alongside traditional physical therapy modalities and emerging digital health solutions by emphasizing clinical workflow efficiency, boasting a three-minute patient setup time, and integrating gamified biofeedback for patient engagement.

Robokinetics' growth trajectory is rooted in its academic origins at Carlos III University of Madrid, transitioning from deep tech research into a commercial medical device enterprise. With a primary focus on clinical settings treating stroke and acquired brain injury recovery, the company aims to reduce manual workloads for physical therapists while scaling its assistive technology footprint. Detailed metrics regarding historical funding rounds, employee headcount growth, and explicit financial inflection points remain limited in public datasets.